Evidence map›Paper›PMID 21500881›Full record

ArticleBehavioral neuroscience2011

Developmental and withdrawal effects of adolescent AAS exposure on the glutamatergic system in hamsters.

Maria Carrillo, Lesley A Ricci, Richard H Melloni

Abstract read
In one paragraph

Article in Behavioral neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maria CarrilloBehavioral Neuroscience Program, Department of Psychology, Northeastern University, Boston, MA 02155, USA.
Lesley A Ricci
Richard H Melloni
Northeastern University · US

Funding

ADOLESCENT ANABOLIC STEROIDS, VASOPRESSIN AND AGGRESSIONR01DA010547 · NIDA · NORTHEASTERN UNIVERSITY · PI MELLONI, RICHARD H. · 2003 to 2015
$2.8M
ADOLESCENT ANABOLIC STEROIDS, VASOPRESSION, &AGGRESSIONR29DA010547 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELLONI, RICHARD H. · 1996 to 2002
$137k
NIDA NIH HHS DA10547NIDA NIH HHS R01 DA010547NIDA NIH HHS R29 DA010547
6 · The paper itself

Abstract

In the Syrian hamster (Mesocricetus auratus) glutamate activity has been implicated in the modulation of adolescent anabolic-androgenic steroid (AAS)-induced aggression. The current study investigated the time course of adolescent AAS-induced neurodevelopmental and withdrawal effects on the glutamatergic system and examined whether these changes paralleled those of adolescent AAS-induced aggression. Glutamate activity in brain areas comprising the aggression circuit in hamsters and aggression levels were examined following 1, 2, 3, and 4 weeks of AAS treatment or 1, 2, 3, and 4 weeks following the cessation of AAS exposure. In these studies glutamate activity was examined using vesicular glutamate transporter 2 (VGLUT2). The onset of aggression was observed following 2 weeks exposure to AAS and continued to increase showing maximal aggression levels after 4 weeks of AAS treatment. This aggressive phenotype was detected after 2 weeks of withdrawal from AAS. The time-course of AAS-induced changes in latero-anterior hypothalamus (LAH)-VGLUT2 closely paralleled increases in aggression. Increases in LAH-VGLUT2 were first detected in animals exposed to AAS for 2 weeks and were maintained up to 3 weeks following the cessation of AAS treatment. AAS treatment also produced developmental and long-term alterations in VGLUT2 expression within other aggression areas. However, AAS-induced changes in glutamate activity within these regions did not coincide with changes in aggression. Together, these data indicate that adolescent AAS treatment leads to alterations in the glutamatergic system in brain areas implicated in aggression control, yet only alterations in LAH-glutamate parallel the time course of AAS-induced changes in the aggressive phenotype.

Indexed as

AdolescentAggressionAnabolic AgentsAndrogensAnimalsBrainCricetinaeDisease Models, AnimalDrug Administration ScheduleGlutamic AcidHumansHypothalamusMaleNandroloneNandrolone DecanoateNeuronsAnabolic AgentsAndrogensboldenone undecylenateGlutamic AcidNandroloneNandrolone DecanoateTestosteronetestosterone 17 beta-cypionateVesicular Glutamate Transport Protein 2

Identifiers

PMID21500881
PMCPMC3131051
OpenAlexW2021329882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.